COMMUNIQUÉS West-GlobeNewswire

Sharps Compliance Announces That Montana Will Purchase Medication Disposal Kiosks Via Recently Awarded Partnership for Success Grant
10/09/2018
The Addictive and Mental Disorders Division (AMDD) of the Montana Department of Public Health and Human Services (DPHSS) plans to place 212 medication collection kiosks throughout the state HOUSTON, Sept. 10, 2018 ( [...]
GUERBET : Information sur les opération effectuées dans le cadre du programme de rachat d'actions
10/09/2018
Villepinte (France), le 10 septembre 2018 Le présent document a pour finalité de présenter les opérations réalisées dans le cadre du programme de rachat d'actions autorisé par l'Assemblée Générale Mixte du 25 mai 2018 [...]
Biodesix Pipeline Test Demonstrates Utility in Triaging Patients with Lung Nodules in New CHEST Data Publication
10/09/2018
Independent Study Data Shows Noninvasive Test Could Eliminate the Biopsy Needle, Lower Patient Anxiety and Costs BOULDER, Colo., Sept. 10, 2018 (GLOBE NEWSWIRE) -- Biodesix today announced newly published data showing [...]
The American Health Council Names Norman Tomaka, BS, Pharm.MS, FAPhA to its Industry Board
10/09/2018
NEW YORK, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Norman Tomaka, BS, Pharm.MS, FAPhA is named to the American Health Council’s Industry Board. A clinical consultant pharmacist at Consultant Pharmacist Services in Melbourne, [...]
Progressive Care Announces Newly Redesigned Website for Wholly-Owned Subsidiary PharmCo, LLC
10/09/2018
PharmCo’s New Website to Bring More Focus on Robust Offering of Telepharmacy Products and Services MIAMI, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and [...]
Opiant Pharmaceuticals, Inc. and Consort Medical plc Announce Manufacturing Agreement for OPNT003, Intranasal Nalmefene, for Treatment of Opioid Overdose
10/09/2018
SANTA MONICA, Calif., and HEMEL HEMPSTEAD, United Kingdom, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing pharmacological [...]
Medibio Provides Market Update
10/09/2018
SYDNEY, Australia and MINNEAPOLIS, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Medibio Limited ( MEB or the Company ) (ASX: MEB) (OTCQB: MDBIF), a mental health technology company, today provides a market update to the last [...]
DLT Resolution to Provide Canadian Premier TV Broadcaster Secure Data Digitization Service
10/09/2018
LAS VEGAS, NV , Sept. 10, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE - DLT Resolution Inc. (OTC: DLTI) a Distributed Ledger Technology (“Blockchain”) and Information Technology company that services the healthcare and [...]
Emerald Health Therapeutics Named as Cannabis Supplier by Newfoundland Labrador Liquor Corporation to Provide Adult-Use Cannabis Products
10/09/2018
VICTORIA, British Columbia, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) (“Emerald”) has been selected as an authorized cannabis supplier by the Newfoundland Labrador [...]
HempAmericana CEO Issues Letter on Shift to Commercial-Stage Operations
10/09/2018
NEW YORK, Sept. 10, 2018 (GLOBE NEWSWIRE) -- HempAmericana, Inc.(GlobeNewsWire)—via OTC PR WIRE-- (OTC:HMPQ) (“HempAmericana” or the “Company”) CEO issues the following letter to Shareholders: Dear Valued Shareholder, [...]
Endocyte Announces FDA Acceptance of Radiographic Progression Free Survival (rPFS) as an Alternative Primary Endpoint of the VISION Trial in Addition to Overall Survival (OS)
10/09/2018
Demonstrating benefit in rPFS versus control, with no detriment to OS, sufficient for full approval A positive assessment on either rPFS or OS is sufficient for full approval rPFS analysis expected late 2019, [...]
BioDelivery Sciences to Present at the 2018 Janney Montgomery Scott Healthcare Conference
10/09/2018
RALEIGH, N.C., Sept. 10, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ:BDSI), a leading commercial stage specialty pharmaceutical company dedicated to patients living with chronic pain, today [...]
Pieris Pharmaceuticals Appoints Peter Kiener, D.Phil. to its Board of Directors
10/09/2018
BOSTON, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) , a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin ® technology platform for [...]
Selecta Biosciences to Present at the Janney Healthcare Conference on September 17, 2018
10/09/2018
WATERTOWN, Mass., Sept. 10, 2018 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (Nasdaq: SELB), a clinical-stage biopharmaceutical company focused on unlocking the full potential of biologic therapies by mitigating [...]
Novo Nordisk A/S - Share repurchase programme
10/09/2018
Bagsværd, Denmark, 10 September 2018 - On 10 August 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April [...]
Aurora Cannabis to Acquire South American Market Leader ICC Labs
10/09/2018
Transaction Establishes Strong Foundation for Aurora’s South American Growth Strategy in Medical, Adult Consumer Use and CBD Wellness Markets EDMONTON, Alberta and VANCOUVER, British Columbia, Sept. 10, 2018 (GLOBE [...]
VIVUS Announces 1-for-10 Reverse Stock Split
10/09/2018
CAMPBELL, Calif., Sept. 10, 2018 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) (the “Company”), a biopharmaceutical company, announced today that the Company’s stockholders approved a reverse stock split. Effective [...]
Amryt receives IND approval from FDA for AP101 enabling the opening of US clinical trial sites
10/09/2018
10 September 2018 AIM: AMYT ESM: AYP Amryt Pharma plc (“Amryt” or the “Company”) Amryt receives IND approval from FDA for AP101 enabling the opening of US clinical trial sites Amryt, a biopharmaceutical company focused [...]
Oncolytics Biotech® Collaborates with SOLTI to Conduct a Window of Opportunity Study in Breast Cancer with Pelareorep
10/09/2018
CALGARY, Alberta and SAN DIEGO, Calif., Sept. 10, 2018 (GLOBE NEWSWIRE) -- Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (TSX: ONC), currently developing REOLYSIN ® (pelareorep), an intravenously delivered immuno-oncolytic [...]

Pages